Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug recognized in Canada for addressing Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adults . The medication functions as a prodrug, https://buysandozlisdexamfetamin110241.daneblogger.com/41996247/lisdexamfetamine-in-canada-a-comprehensive-guide